Keele Research Repository

Article

Strange, RC, König, CS, Ahmed, A, Hackett, G, Haider, A, Haider, KS, Desnerck, P, Saad, F, Lorde, N, Maarouf, A and Ramachandran, S (2021) Testosterone Therapy: Increase in Hematocrit is Associated with Decreased Mortality. Androgens: Clinical Research and Therapeutics, 2 (1). 150 - 159.

Lorde, N, Maarouf, A, Strange, RC, König, CS, Hackett, G, Haider, A, Haider, KS, Desnerck, P, Saad, F and Ramachandran, S (2021) Testosterone Therapy in Adult-Onset Testosterone Deficiency: Hematocrit and Hemoglobin Changes. Androgens: Clinical Research and Therapeutics, 2 (1). 141 - 149.

Ramachandran, S, Hackett, GI and Strange, RC (2020) Testosterone replacement therapy: Pre-treatment sex hormone binding globulin levels and age may identify clinical subgroups. Andrology.

Strange, RC, Ramachandran, S and Hackett, GI (2019) Sex hormone binding globulin: A review of its interactions with testosterone and age, and its impact on mortality in men with type 2 diabetes. Sexual Medicine Reviews.

Strange, RC, Ramachandran, S, Livingston, M and Hackett, GI (2019) Should laboratory assay quality be described in study publications and clinical guidelines? A focus on testosterone assay performance. Edorium Journal of Biochemistry.

Strange, RC, Ramachandran, S, Hackett, GI, Balabani, S and König, CS (2019) Testosterone therapy: An assessment of the clinical consequences of changes in haematocrit and blood flow characteristics. Sexual Medicine Reviews.

Strange, RC, Ramachandran, S, Hackett, GI, Mulay, A and Cole, N (2019) Long-term Testosterone Therapy in Type 2 Diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors. BJU International, 123 (3). pp. 219-529.

Ramachandran, S, Strange, RC, Fryer, AA, Saad, F and Hackett, GI (2018) The association of sex hormone binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes. Andrology, 6 (6). pp. 846-853.

Hackett, GI, Cole, N, Mulay, A, Strange, RC and Ramachandran, S (2018) Long-term testosterone therapy in type 2 diabetes is associated with decreasing waist circumference and improving erectile function. World Journal of Men's Health, 38 (1). pp. 68-77.

Ramachandran, S, Konig, C, Hackett, G, Livingston, M and Strange, RC (2018) Managing Clinical Heterogeneity: An Argument for Benefit-Based Action Limits. Journal of Engineering in Medical Diagnostics and Therapy, 1 (3).

Hackett, G, Cole, N, Saghir, A, Jones, P, Strange, RC and Ramachandran, S (2017) Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study. Andrology, 5 (5). 905 - 913.

Hackett, G, Ramachandran, S, Strange, R and Jones, PW (2016) 004 Long Term Therapy With Testosterone Undecanoate in Type 2 Diabetes was Associated With Reduced All-Cause Mortality but no Significant Improvement in Conventional Risk Factors for CVD. The Journal of Sexual Medicine, 14 (1). S2 - S3.

Groves, C, Shetty, C, Strange, RC, Waldron, J and Ramachandran, S (2016) A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels. Postgraduate Medical Journal, 93 (1098). pp. 205-208.

Hackett, G, Cole, N, Saghir, A, Jones, P, Strange, RC and Ramachandran, S (2016) Testosterone Undecanoate improves Sexual Function in Men with Type 2 diabetes and Severe Hypogonadism: Results from a 30 week randomized placebo controlled study. BJU Int, 118 (5). pp. 804-813.

Strange, RC, Shipman, KE and Ramachandran, S (2015) Metabolic syndrome: a review of the role of vitamin D in mediating susceptibility and outcome. World Journal of Diabetes, 6 (7). 896 - 911.

Rukin, NJ, Zeegers, MP, Ramachandran, S, Luscombe, CJ, Liu, S, Saxby, M, Lear, J and Strange, RC (2007) A comparison of sunlight exposure in men with prostate cancer and basal cell carcinoma. British Journal of Cancer, 96 (3). 523 -528.

Book Section

Ramachandran, S, Bhartia, M, Jones, A and Strange, RC (2019) PCSK9 Inhibitors in Diabetic Dyslipidemia. In: RSSDI Diabetes Update 2018. J P Medical Publishers, pp. 374-378.

Ramachandran, S, Bhartia, M, Jones, A and Strange, RC (2018) Use of fibrates in the Metabolic Syndrome and Diabetics: practical tips. In: RSSDI Diabetes Update 2018. J P Medical Publishers, pp. 356-361.